Lanthanum Carbonate 1000mg Chewable Tablets Recalled for Broken and Crushed Tablets
Cipla USA is recalling Lanthanum Carbonate Chewable Tablets, 1000mg due to complaints of crushed and broken tablets. The recall affects 1,875 boxes distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall based on failed tablet specifications (crushed and broken tablets). The source documents no associated illnesses, injuries, or hospitalizations. The hazard is a physical defect affecting product integrity rather than chemical or biological safety.
Plain-English summary
Cipla USA, Inc. is recalling Lanthanum Carbonate Chewable Tablets, 1000mg (10-count bottles) due to failed tablet specifications. The company received complaints that tablets in affected lots are crushed or broken.
The recalled product (NDC 69097-0936-98, Lot #NB240316, Exp 12/31/25) was distributed nationwide. The recall affects approximately 1,875 boxes.
The recalled product
- Product
- Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
- Manufacturer
- Cipla USA, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- broken-tablets
- crushed-tablets
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # NB240316
- Exp 12/31/25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27